TB-500 vs GHK-Cu

Overview

TB-500 and GHK-Cu are two peptides marketed for tissue repair and healing, but they work through fundamentally different mechanisms. TB-500 is a fragment of thymosin beta-4 involved in cell migration, while GHK-Cu is a copper-carrying tripeptide involved in wound healing and tissue remodeling. Neither is approved for clinical use.

Understanding their differences is important because they are often discussed in regenerative medicine contexts.

Key Facts

Aspect	TB-500	GHK-Cu
Full Name	Thymosin Beta-4 Fragment	Glycyl-L-Histidyl-L-Lysine:Copper
Parent Compound	Thymosin beta-4 (Tβ4)	Naturally occurring tripeptide
Structure	43 amino acid peptide	Tripeptide + copper ion
FDA Status	Not approved	Not approved
Regulatory Note	WADA prohibited	Not prohibited

Structure and Origin

Aspect	TB-500	GHK-Cu
Amino Acids	43	3
Molecular Weight	~4,963 Da	~403 Da
Metal Component	None	Copper (Cu²⁺)
Natural Source	Derived from Tβ4	Found in blood plasma

TB-500 Structure

• Synthetic fragment of thymosin beta-4
• Contains active region of parent molecule
• Marketed as equivalent to Tβ4 (debated)
• Large peptide requiring injection

GHK-Cu Structure

• Small tripeptide (Gly-His-Lys)
• Copper ion bound to peptide
• Naturally occurs in human plasma
• Levels decline with age

Mechanism Comparison

Aspect	TB-500	GHK-Cu
Primary Action	Actin sequestration, cell migration	Copper delivery, gene modulation
Cell Effects	Migration, differentiation	Remodeling, synthesis
Target Tissues	Multiple (systemic)	Skin, connective tissue
Key Pathway	Cytoskeletal reorganization	Matrix metalloproteinases, collagen

TB-500 Proposed Mechanisms

1. G-Actin Sequestration

   • Binds monomeric actin
   • Regulates polymerization
   • Affects cell motility

2. Cell Migration

   • Promotes endothelial cell migration
   • Facilitates wound healing
   • Enables tissue repair

3. Anti-Inflammatory

   • Reduces inflammatory markers
   • Proposed systemic effects

GHK-Cu Proposed Mechanisms

1. Copper Delivery

   • Transports copper to cells
   • Essential for enzyme function
   • Supports tissue repair

2. Gene Modulation

   • Upregulates collagen synthesis
   • Increases elastin production
   • Affects 4,000+ genes (studies claim)

3. Tissue Remodeling

   • Activates tissue remodeling
   • Attracts immune cells
   • Stimulates angiogenesis

Evidence Comparison

Factor	TB-500	GHK-Cu
Human RCTs	None (TB-500 specifically)	Few (mostly cosmetic)
Animal Studies	Some (Tβ4 extrapolation)	Numerous
Research Quality	Low	Moderate
Independent Replication	Limited	Better

TB-500 Evidence Limitations

Issue	Detail
Extrapolation	Most data from thymosin beta-4, not TB-500
Assumption	TB-500 ≠ proven equivalent to Tβ4
Human trials	None specific to TB-500
Tβ4 trials	RegeneRx conducted some (different product)

GHK-Cu Evidence

Source	Quality
In vitro	Numerous studies
Animal models	Multiple wound healing studies
Human (topical)	Cosmetic product studies
Human (injectable)	Very limited

Administration Routes

Aspect	TB-500	GHK-Cu
Subcutaneous	Yes (common)	Possible (less common)
Intramuscular	Yes	Not typical
Topical	Not practical	Yes (cosmetics)
Oral	Not bioavailable	Not bioavailable

Route Selection

Factor	TB-500	GHK-Cu
Systemic effects	Injection required	Injection (if systemic)
Local skin effects	N/A	Topical effective
Convenience	Injection only	Topical option
Cosmetic use	Not typical	Primary application

Application Comparison

Wound Healing

Factor	TB-500	GHK-Cu
Proposed Action	Cell migration	Matrix remodeling
Evidence	Extrapolated (Tβ4)	Direct (topical)
Application	Systemic injection	Topical or injection

Skin and Cosmetic

Factor	TB-500	GHK-Cu
Anti-aging claims	Limited	Primary focus
Collagen effects	Indirect	Direct
Commercial products	None	Many cosmetics

Musculoskeletal

Factor	TB-500	GHK-Cu
Muscle claims	Flexibility, repair	Limited
Joint claims	Some	Limited
Evidence	Very limited	Very limited

Side Effect Profiles

TB-500 Reported Effects

Effect	Frequency
Fatigue	Occasional
Head rush/flushing	Occasional
Injection site reaction	Common
Unknown long-term	No data

GHK-Cu Reported Effects

Effect	Frequency
Skin irritation (topical)	Occasional
Injection site reaction	If injected
Systemic effects	Unknown (injectable)
Generally mild (topical)	Common experience

Safety Considerations

Factor	TB-500	GHK-Cu
Long-term data	None	Limited
Cancer concerns	Theoretical (cell migration)	Theoretical (angiogenesis)
Drug interactions	Unknown	Unknown
Quality issues	Significant (unregulated)	Variable

Regulatory and Legal Status

Aspect	TB-500	GHK-Cu
FDA Status	Not approved	Not approved (cosmetic OK)
WADA Status	Prohibited (S0)	Not prohibited
Clinical Development	Tβ4 (RegeneRx) - separate	Limited
Commercial Use	Research chemical	Cosmetic ingredient

Key Regulatory Difference

• TB-500: Prohibited in sports, research chemical only
• GHK-Cu: Legal in cosmetics, research chemical for injection

Practical Considerations

Factor	TB-500	GHK-Cu
Ease of use	Requires injection	Topical or injection
Storage	Refrigerated	Stable (varies by form)
Reconstitution	Required	Depends on source
Cost	Moderate	Variable

Source Quality Concerns

Both peptides share quality challenges:

Issue	Impact
Unregulated sources	Unknown purity
Testing unavailable	Cannot verify content
Contamination	Possible
Degradation	Activity may be lost

Summary

Factor	TB-500	GHK-Cu
Structure	Large peptide (43 AA)	Small tripeptide + copper
Mechanism	Cell migration/actin	Copper/gene modulation
Evidence Level	Moderate	Moderate
Administration	Injection only	Topical or injection
Primary Use	Recovery (claimed)	Skin/wound healing
WADA Status	Prohibited	Not prohibited
Commercial Products	None	Many cosmetics

Key Takeaways

1. Different mechanisms: TB-500 affects cell migration; GHK-Cu delivers copper and modulates genes
2. GHK-Cu has more direct evidence: Actual studies on the compound itself
3. TB-500 evidence is extrapolated: Most research is on parent compound Tβ4
4. GHK-Cu has topical use: Established in cosmetic products for skin
5. TB-500 requires injection: No practical topical or oral route
6. WADA difference: TB-500 banned; GHK-Cu not banned
7. Neither FDA approved: Both unapproved for therapeutic use
8. Quality concerns apply to both: Unregulated sources have unknown purity

---

This comparison is for educational purposes only. Neither peptide is approved by regulatory agencies for therapeutic use. Products sold as research chemicals have uncertain quality and safety.